AbbVie’s third-quarter sales and adjusted profit per share topped analysts’ estimates, and it raised both 2026 forecasts above estimates. The results point to stronger business prospects, with no weaker company result described.
The results show growth in sales and profit, and the company now expects more sales and adjusted profit for the full year. Each reported result beat analysts’ estimates, with no weaker company result described.
Follow AbbVie Inc. (ABBV) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ABBV